alexa
Indianmoney.com Missed Call Number
 
Home News Almirall seeks nod for tildrakizumab in Europe: Sun Pharma

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Business InsuranceClick Here
 
 
Almirall seeks nod for tildrakizumab in Europe: Sun Pharma

Almirall seeks nod for tildrakizumab in Europe: Sun Pharma

Friday, March 24, 2017, 3:41 PM

Drug major Sun Pharmaceutical Industries said Spain-based Almirall S.L has sought regulatory approval from the European Medicines Agency for a new drug, tildrakizumab. The drug is being evaluated for the treatment of moderate-to-severe plaque psoriasis, the two companies said in a statement. In July 2016, Almirall entered into a licensing agreement with Sun Pharma for the development and commercialisation of tildrakizumab in Europe.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!